Search results
AbbVie (NYSE:ABBV) Shares Down 0.1%
ETF DAILY NEWS· 14 hours agoAbbVie Inc. (NYSE:ABBV – Get Free Report)’s stock price dropped 0.1% during mid-day trading on Thursday . The stock traded as low as $157.76 and last traded at $159.38. Approximately 903,885 ...
AbbVie (NYSE:ABBV) Now Covered by Cantor Fitzgerald
ETF DAILY NEWS· 7 days agoCantor Fitzgerald assumed coverage on shares of AbbVie (NYSE:ABBV – Get Free Report) in a research note issued to investors on Friday, MarketBeat.com reports. Cantor Fitzgerald’s price objective ...
Stress can be "the triggering factor" for skin problems. Dermatologists share their advice. - WDEF
WDEF Chattanooga· 4 days agoDermatologist Dr. Afton Cobb says she sees patients all the time who notice “the triggering factor...
Nektar Therapeutics (NASDAQ:NKTR) Given Consensus Recommendation of “Hold” by Analysts
ETF DAILY NEWS· 7 days agoNektar Therapeutics (NASDAQ:NKTR – Get Free Report) has received an average recommendation of “Hold” from the five ratings firms that are covering the stock, Marketbeat reports. Jefferies Financial ...
Are Saunas Good for Your Skin? Discover How Women Over 50 Can Sweat Their Way to a More Radiant,...
Fort Worth Star-Telegram· 4 days agoRelax and rejuvenate in no time!
Jonathan Zalevsky Sells 7,355 Shares of Nektar Therapeutics (NASDAQ:NKTR) Stock
ETF DAILY NEWS· 4 days agoNektar Therapeutics (NASDAQ:NKTR – Get Free Report) insider Jonathan Zalevsky sold 7,355 shares of the stock in a transaction that occurred on Friday, May 17th. The shares were sold at an average ...
Howard W. Robin Sells 16,650 Shares of Nektar Therapeutics (NASDAQ:NKTR) Stock
ETF DAILY NEWS· 4 days agoNektar Therapeutics (NASDAQ:NKTR – Get Free Report) CEO Howard W. Robin sold 16,650 shares of the company’s stock in a transaction on Friday, May 17th. Following the completion of the transaction ...
MoonLake Immunotherapeutics (NASDAQ:MLTX) Stock Rating Reaffirmed by HC Wainwright
ETF DAILY NEWS· 7 days agoMoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at HC Wainwright in a report released on Friday, Benzinga reports. HC ...
Swiss National Bank Cuts Stake in Protagonist Therapeutics, Inc. (NASDAQ:PTGX)
ETF DAILY NEWS· 19 hours agoSwiss National Bank trimmed its position in shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) by 9.8% in the 4th quarter, according to the company in its most recent Form ...
